SBI Life Insurance Company
- Market Cap
- ₹1,83,272 Cr
- P/E
- 69.00
Key Fundamentals
LargecapInsuranceFinancial ServicesPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 15.00%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹26.47
- Book Value
- ₹204.69
- Market Cap
- ₹1,83,272 Cr
- P/E (TTM)
- 69.00
- P/B
- 8.92
- ROE
- 13.70%
- Dividend Yield
- 0.15%
- EBITDA
- ₹2,813 Cr
- 52W High
- ₹2,132.00
- 52W Low
- ₹1,607.70
- Day Range
- ₹1,791.60 – ₹1,826.80
- Volume
- 7,17,534
Peer Comparison
Financial Services › Insurance › Life Insurance
| 410.70 | 8.37 | 5,19,535 | 2.74 | 2.50% | 37.80% | 35.10% | 10,17,885 | 62,071 | |
| 1,826.50 | 69.00 | 1,83,272 | 8.92 | 0.15% | 13.70% | 15.00% | 1,21,160 | 2,656 | |
| 588.65 | 62.23 | 1,27,889 | 6.57 | 0.36% | 11.30% | 10.30% | 1,07,513 | 2,048 | |
| 462.00 | 41.66 | 67,047 | 4.91 | 0.37% | 12.60% | 10.10% | 52,714 | 1,608 | |
| 1,435.10 | 266.25 | 49,527 | 8.66 | 0.00% | 1.52% | 2.87% | 51,631 | 231 | |
| 127.32 | 90.30 | 12,095 | 7.38 | 0.31% | 8.11% | 8.35% | 12,482 | 134 | |
| Median 6 companies | 525.33 | 65.62 | 97,468 | 6.98 | 0.33% | 11.95% | 10.20% | 80,114 | 1,828 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 97/100
Category scores
- Quality
- 66
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 29
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 56
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 73
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 37
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 48
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Company is expected to give good quarter
Weaknesses
5- Stock is trading at 8.92 times its book value
- The company has delivered a poor sales growth of 6.52% over past five years.
- Tax rate seems low
- Earnings include an other income of Rs.2,003 Cr.
- Dividend payout has been low at 12.2% of profits over last 3 years
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 3 | 4 | 12 |
| Oscillators | Bullish | 2 | 4 | 3 |
| Moving Averages | Strong Bullish | 1 | 0 | 9 |
Oscillators
Bullish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 63.48
- Neutral
- MACD (12,26,9)
- 33.23
- Bullish
- SMA (50)
- 1,716.55
- Bullish
- SMA (200)
- 1,827.59
- Bearish
As of
Analyst Rating
33 of 34 analysts rate Buy, 1 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +19.24% |
|---|---|
| 5Y | +6.52% |
| 3Y | +11.68% |
| 1Y | −3.91% |
| TTM | +16.45% |
Net profit
| 10Y | +11.34% |
|---|---|
| 5Y | +11.15% |
| 3Y | +12.80% |
| 1Y | +2.36% |
| TTM | +8.23% |
Operating cash flow
| 10Y | +19.57% |
|---|---|
| 5Y | +7.65% |
| 3Y | +6.41% |
| 1Y | +35.14% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −3.99 pp |
|---|---|
| 5Y | −0.29 pp |
| 3Y | −1.61 pp |
| 1Y | −0.44 pp |
| TTM | −0.55 pp |
Revenue by year
| Mar 2017 | ₹30,548 Cr |
|---|---|
| Mar 2018 | ₹34,068 Cr |
| Mar 2019 | ₹44,604 Cr |
| Mar 2020 | ₹43,798 Cr |
| Mar 2021 | ₹81,913 Cr |
| Mar 2022 | ₹82,983 Cr |
| Mar 2023 | ₹80,636 Cr |
| Mar 2024 | ₹1,31,988 Cr |
| Mar 2025 | ₹1,16,888 Cr |
| Mar 2026 | ₹1,12,315 Cr |
Net profit by year
| Mar 2017 | ₹955 Cr |
|---|---|
| Mar 2018 | ₹1,150 Cr |
| Mar 2019 | ₹1,327 Cr |
| Mar 2020 | ₹1,422 Cr |
| Mar 2021 | ₹1,456 Cr |
| Mar 2022 | ₹1,506 Cr |
| Mar 2023 | ₹1,721 Cr |
| Mar 2024 | ₹1,894 Cr |
| Mar 2025 | ₹2,413 Cr |
| Mar 2026 | ₹2,470 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
SBI Life Insurance trades at a PE of 68.18 and a price-to-book of 8.82 as of 2026-11-19, with a market cap of Rs.1,81,074 Cr. The company is virtually debt-free and has compounded profits at 11% over ten years, though its stock has declined 11% over the past one year and sales growth over five years has been a modest 7%.
- The company is almost debt-free with a debt-to-equity ratio of 0, providing significant financial flexibility and resilience against interest-rate cycles.
- Compounded sales growth of 19% over 10 years demonstrates a long track record of sustained revenue expansion in the underpenetrated Indian life insurance market.
- Return on equity has been consistently healthy at 14-15% across 3-year, 5-year, and 10-year periods, with the last year at 14%.
- TTM revenue growth has accelerated to 16%, well above the 7% five-year compounded sales growth, suggesting a recent pickup in business momentum.
- Compounded profit growth of 13% over three years outpaces the longer-term 10-year profit CAGR of 11%, indicating improving profitability trends.
- The stock is trading about 15.4% below its 52-week high of Rs.2,132, which may reflect some of the near-term concerns already being priced in.
- The company is expected to deliver a good upcoming quarter, which could act as a near-term catalyst for sentiment improvement.
- At a trailing PE of 68.18, the stock commands a steep earnings premium, leaving little room for execution misses or earnings disappointments.
- Price-to-book of 8.82 is elevated; the stock trades at nearly 9 times book value, which demands sustained high-return performance to justify.
- Five-year compounded sales growth of only 7% is notably weak for a company in a high-growth sector and trading at such rich valuations.
- TTM profit growth has slowed to 8%, down from 13% over three years and 11% over five years, pointing to a potential deceleration in earnings momentum.
- Dividend yield is just 0.15% and the payout ratio has been only 12.2% of profits over the last three years, offering minimal income return to shareholders.
- Earnings include other income of Rs.2,003 Cr, raising questions about the quality and sustainability of reported profits.
- The stock has delivered a negative 1-year return of -11%, underperforming during a period when broader markets have generally held up, suggesting sector or company-specific headwinds.
- The apparently low tax rate warrants scrutiny, as any normalisation of the effective tax rate could compress net earnings going forward.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: SBI Life delivered steady Q2FY27 results with 11% profit growth and healthy premium income expansion, supported by a large embedded value base of ₹873.5 billion. No material headwinds surfaced in the recent news flow. Governance activity remains routine with a new independent director nomination. The trend is stable, and upcoming investor conferences may provide further clarity on growth outlook.
- Q2FY27 PAT up 11% YoY Oct 27
SBI Life reported net profit of ₹549 crore in Q2FY27, up 11% YoY. Gross premium income grew 8.2% YoY and embedded value stood at ₹873.5 billion.
- Investor meets scheduled Nov 2026 Nov 11
SBI Life will interact with investors at conferences in Mumbai and Singapore during November 2026.
- New independent director proposed Nov 3
SBI Life issued a postal ballot seeking shareholder approval for the appointment of Nihar Niranjan Jambusaria as an Independent Director.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28,805 | 39,033 | 36,255 | 34,654 | 40,302 | 18,862 | 23,071 | 38,996 | 23,115 | 46,133 | 4,071 | 46,337 | 24,620 |
| Expenses | 28,392 | 38,681 | 37,043 | 34,060 | 39,696 | 18,266 | 23,520 | 38,333 | 22,600 | 45,517 | 5,117 | 45,579 | 24,058 |
| Operating Profit | 413 | 352 | −788 | 594 | 606 | 596 | −449 | 664 | 516 | 615 | −1,046 | 757 | 562 |
| OPM % | 1.4% | 0.9% | −2.2% | 1.7% | 1.5% | 3.2% | −1.9% | 1.7% | 2.2% | 1.3% | −26% | 1.6% | 2.3% |
| Other Income | 12 | 18 | 1,639 | 3 | −4 | −3 | 1,350 | −8 | 16 | 27 | 1,913 | 36 | 28 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 424 | 370 | 851 | 597 | 601 | 594 | 901 | 656 | 532 | 642 | 867 | 793 | 590 |
| Tax % | 10% | 13% | 5% | 13% | 12% | 7% | 10% | 9% | 7% | 10% | 7% | 9% | 7% |
| Net Profit | 380 | 322 | 811 | 520 | 529 | 551 | 814 | 594 | 495 | 577 | 805 | 725 | 549 |
| EPS (₹) | 3.80 | 3.21 | 8.10 | 5.19 | 5.28 | 5.50 | 8.12 | 5.93 | 4.93 | 5.75 | 8.02 | 7.23 | 5.47 |
| YoY Sales growth | 4 | 46 | 70 | 24 | 40 | −52 | −36 | 13 | −43 | 145 | −82 | 19 | 7 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23,299 | 19,324 | 30,548 | 34,068 | 44,604 | 43,798 | 81,913 | 82,983 | 80,636 | 1,31,988 | 1,16,888 | 1,12,315 | 1,21,160 |
| Expenses | 22,505 | 18,404 | 29,479 | 32,736 | 43,130 | 42,447 | 81,040 | 82,254 | 78,713 | 1,29,884 | 1,15,469 | 1,11,451 | 1,20,271 |
| Operating Profit | 794 | 920 | 1,068 | 1,332 | 1,474 | 1,351 | 872 | 730 | 1,923 | 2,104 | 1,420 | 864 | 889 |
| OPM % | 3.4% | 4.8% | 3.5% | 3.9% | 3.3% | 3.1% | 1.1% | 0.9% | 2.4% | 1.6% | 1.2% | 0.8% | 0.7% |
| Other Income | 183 | 129 | 139 | 156 | 266 | 529 | 867 | 1,032 | 51 | 50 | 1,357 | 1,948 | 2,003 |
| Interest | 4 | 5 | 5 | 6 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 34 | 37 | 48 | 59 | 92 | 89 | 99 | 75 | 68 | 76 | 84 | 115 | 0 |
| PBT | 939 | 1,007 | 1,154 | 1,422 | 1,642 | 1,790 | 1,640 | 1,687 | 1,906 | 2,078 | 2,693 | 2,697 | 2,892 |
| Tax % | 13% | 16% | 17% | 19% | 19% | 21% | 11% | 11% | 10% | 9% | 10% | 8% | — |
| Net Profit | 815 | 844 | 955 | 1,150 | 1,327 | 1,422 | 1,456 | 1,506 | 1,721 | 1,894 | 2,413 | 2,470 | 2,656 |
| EPS (₹) | 8.15 | 8.44 | 9.55 | 11.50 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.91 | 24.08 | 24.63 | 26.47 |
| Div. Payout % | 15% | 14% | 16% | 17% | 15% | 0% | 17% | 13% | 15% | 14% | 11% | 11% | — |
| Sales growth | 35 | −17 | 58 | 12 | 31 | −2 | 87 | 1 | −3 | 64 | −11 | −4 | 16 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,001 | 1,001 | 1,002 | 1,003 | 1,003 |
| Reserves | 3,056 | 3,733 | 4,552 | 5,528 | 6,576 | 7,743 | 9,400 | 10,622 | 12,017 | 13,907 | 15,983 | 18,083 | 19,536 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 70,064 | 78,696 | 96,687 | 1,15,193 | 1,39,157 | 1,56,837 | 2,16,430 | 2,61,715 | 3,01,582 | 3,83,369 | 4,40,110 | 4,80,960 | 5,17,836 |
| Total Liabilities | 74,121 | 83,429 | 1,02,240 | 1,21,720 | 1,46,734 | 1,65,580 | 2,26,830 | 2,73,337 | 3,14,599 | 3,98,277 | 4,57,095 | 5,00,046 | 5,38,375 |
| Fixed Assets | 292 | 301 | 507 | 511 | 563 | 568 | 564 | 919 | 520 | 551 | 580 | 647 | 735 |
| CWIP | 7 | 146 | 31 | 70 | 32 | 13 | 1 | 3 | 1 | 6 | 10 | 41 | 0 |
| Investments | 69,385 | 77,843 | 95,830 | 1,14,436 | 1,39,325 | 1,58,813 | 2,18,756 | 2,64,437 | 3,04,334 | 3,85,590 | 4,47,467 | 4,86,367 | 5,26,359 |
| Other Assets | 4,437 | 5,139 | 5,871 | 6,703 | 6,814 | 6,186 | 7,509 | 7,978 | 9,743 | 12,130 | 9,038 | 12,991 | 11,281 |
| Total Assets | 74,121 | 83,429 | 1,02,240 | 1,21,720 | 1,46,734 | 1,65,580 | 2,26,830 | 2,73,337 | 3,14,599 | 3,98,277 | 4,57,095 | 5,00,046 | 5,38,375 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 2,711 | 5,778 | 8,525 | 10,395 | 13,473 | 19,299 | 23,878 | 21,852 | 28,656 | 29,122 | 25,547 | 34,523 |
| Investing | −178 | −7,204 | −9,032 | −8,910 | −13,552 | −16,986 | −19,203 | −21,611 | −30,203 | −31,221 | −21,789 | −35,318 |
| Financing | −117 | −144 | −144 | −221 | −241 | −198 | 3 | −231 | −415 | −227 | −215 | −179 |
| Net Cash Flow | 2,416 | −1,570 | −651 | 1,264 | −321 | 2,114 | 4,677 | 10 | −1,962 | −2,327 | 3,543 | −974 |
| Free Cash Flow | 2,687 | 5,600 | 8,377 | 10,288 | 13,325 | 19,210 | 23,763 | 21,785 | 28,581 | 29,008 | 25,441 | 34,338 |
| CFO/EBITDA | 341 | 628 | 798 | 780 | 955 | 1,473 | 2,802 | 3,094 | 1,532 | 1,426 | 1,870 | 4,112 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | 0 | −6 | 3 | 3 | 4 | 11 | 1 | −3 | 1 | 4 | 2 | 4 |
| ROCE % | 25% | 23% | 23% | 24% | 22% | 22% | 17% | 15% | 15% | 15% | 17% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view SBI Life Insurance insights
36 extracted metrics across FY14–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · Apr 2026Transcript PPT
- 4 May 2026
- 9 May 2025
- 10 May 2024
- 12 May 2023
- 12 Dec 2022
- General announcements 11 Nov 2026
Frequently Asked Questions about SBI Life Insurance Company
What does SBI Life Insurance Company Ltd do?
Where is SBI Life Insurance Company Ltd (SBILIFE) listed?
Which sector does SBI Life Insurance Company Ltd belong to?
What is the market capitalisation of SBI Life Insurance Company Ltd?
What is the PE ratio of SBI Life Insurance Company Ltd?
What is the 52-week high and low of SBI Life Insurance Company Ltd?
Does SBI Life Insurance Company Ltd pay dividends?
What is the Return on Equity (ROE) of SBI Life Insurance Company Ltd?
Company Information
SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SBILIFE.md for SBI Life Insurance Company Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.